We have located links that may give you full text access.
Study of feasibility and acceptability of subcutaneous implantable ports (SIPs) in cancer patients.
Indian Journal of Pediatrics 2012 December
OBJECTIVE: To assess the feasibility and complication rate associated with Subcutaneous Implantable Ports (SIPs) in pediatric cancer patients.
METHODS: Ninety nine patients underwent chemo port insertion between January2003 to May 2011 with variety of neoplastic diseases. Data was collected with regards to underlying condition, duration the catheter was in situ and complications during insertion, accessing and removal. Chemoport was inserted either at diagnosis or once optimal conditions were achieved. Ports were placed in internal jugular vein (IJV) or subclavian vein (SCV) under general or local anesthesia under strict aseptic conditions in theatre.
RESULTS: A total of 100 ports were placed in 99 patients. The mean duration of the implantable ports was 393 days (range 30-1300). In 49 cases (49%), ports were removed electively, 15 cases (15%) died with port in situ and 36 cases (36%) still have port in situ and receiving chemotherapy without any complications. Complications observed were suspected infection (4%), port fracture (4%), thrombosis of catheter (1%) and blockage (1%).
CONCLUSIONS: The use of ports is safe and feasible in Pediatric Oncology patients if strict asepsis guidelines are followed.
METHODS: Ninety nine patients underwent chemo port insertion between January2003 to May 2011 with variety of neoplastic diseases. Data was collected with regards to underlying condition, duration the catheter was in situ and complications during insertion, accessing and removal. Chemoport was inserted either at diagnosis or once optimal conditions were achieved. Ports were placed in internal jugular vein (IJV) or subclavian vein (SCV) under general or local anesthesia under strict aseptic conditions in theatre.
RESULTS: A total of 100 ports were placed in 99 patients. The mean duration of the implantable ports was 393 days (range 30-1300). In 49 cases (49%), ports were removed electively, 15 cases (15%) died with port in situ and 36 cases (36%) still have port in situ and receiving chemotherapy without any complications. Complications observed were suspected infection (4%), port fracture (4%), thrombosis of catheter (1%) and blockage (1%).
CONCLUSIONS: The use of ports is safe and feasible in Pediatric Oncology patients if strict asepsis guidelines are followed.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app